News & Articles: Product Liability
Chambers UK 2021 – Top Tier Rankings for Henderson Chambers
Following the launch of Chambers UK 2021, Henderson Chambers is delighted to be recommended with 51...
read moreAlerter by Jack Castle – Tilting at Windfalls: Swift v Carpenter and Accommodation Capital Costs
Henderson Chambers alerter by Jack Castle In a long-awaited judgment, the Court of Appeal in...
read moreLegal 500 2021 – Top Tier Rankings for Henderson Chambers
Following the launch of the The Legal 500 UK 2021, Henderson Chambers is delighted to be recommended...
read moreLucy McCormick featured in Tech Dispute Network’s Podcast
Lucy McCormick contributed to the second episode of the Tech Dispute Network's "Need to Know Basis"...
read moreCOVID-19 Briefing Note – Product Liability Trends & Issues
Covid-19 Briefing Note by Noel Dilworth, Angus Withington, Adam Heppinstall, Jonathan Lewis and...
read moreCOVID 19 – Supply chain issues arising from Covid 19 and their ramifications
Alerter by Angus Withington Supply chain issues can arise from political judgments to control the...
read moreCOVID-19 Briefing Note – Commercial Dispute Resolution Trends & Issues
COVID-19 Briefing Note by Henry Warwick QC, Rachel Tandy, George Mallet, Lia Moses and Reanne...
read moreCape v Dring: High Court clarifies the proper approach to applications by non-parties for access to documents
The Cape v Dring litigation concerns an attempt by a non-party to obtain copies of the trial bundle...
read moreChanges to the law of e-scooters
Lucy McCormick explores the issues in an article for New Law Journal. On 4 July 2020, rental...
read moreCOVID-19 – Is Covid-19 sowing the seeds for future litigation?
SAGE Publishing and Medico-Legal Journal have published an article by Toby Riley-Smith QC, Adam...
read moreAddleshaw Goddard and Henderson Chambers secure indemnity costs following judgment being entered for GSK in the long-running Seroxat Pharmaceutical Group Action
Seroxat Litigation: Judgment for GSK with indemnity costs and £4.5m interim payment in landmark...
read moreCOVID-19 – Vaccines, BREXIT & Vaccine Damage Claims
In the wake of the COVID-19 pandemic, the European Pharmaceutical Law Review (EPLR) has establish a...
read moreWould you like to know more?
If you require help or advice please contact our clerking team
Call - +44 (0)20 7583 9020
or email our clerks